Buscar en
Medicina de Familia. SEMERGEN
Toda la web
Inicio Medicina de Familia. SEMERGEN Leukocytoclastic vasculitis and COVID-19 vaccination
Información de la revista
Vol. 48. Núm. 8.
(Noviembre - Diciembre 2022)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 48. Núm. 8.
(Noviembre - Diciembre 2022)
Letter to the Editor
Acceso a texto completo
Leukocytoclastic vasculitis and COVID-19 vaccination
Vasculitis leucocitoclástica y vacunación COVID-19
Visitas
195
P. Sookaromdeea,
Autor para correspondencia
pathumsook@gmail.com

Corresponding author.
, V. Wiwanitkitb
a Private Academic Consultant, Bangkok, Thailand
b Adjunct Professor, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
Dear Editor,

We would like to share ideas on the publication “Leukocytoclastic vasculitis secondary to vaccination against SARS-CoV-2.”1 To summarize, Martn Guerra et al. stated that VLC secondary to the SARS-CoV-2 vaccine can be suspected from the first contact with the patient due to a history of vaccination and a common sign in a physical examination that any professional can do.1 We agree that the COVID-19 vaccine can cause side effects, with leukocytoclastic vasculitis being one among them. The patient in this case developed leukocytoclastic vasculitis, according to the study. However, concluding the vaccine-interrelationship is still problematic. Because there is no information on the patient's health or immune status prior to immunization, it is impossible to rule out the potential of an underlying condition causing leukocytoclastic vasculitis. There is also the possibility of a concomitant medical condition causing leukocytoclastic vasculitis. Dengue fever, for example, may coexist with vaccination,2 and dengue may be the cause of leukocytoclastic vasculitis.3

Funding

None declared.

Conflict of interest

None declared.

References
[1]
J.M. Martín Guerra, M. Moreta Rodríguez.
Leukocytoclastic vasculitis secondary to vaccination against SARS-CoV-2.
[2]
A. Kebayoon, V. Wiwanitkit.
Dengue after COVID-19 vaccination: possible and might be missed.
Clin Appl Thromb Hemost, 27 (2021),
[3]
A. Jose, M. Dhar, P.K. Panda, S. Kishore.
Expanded dengue syndrome with small-medium-vessel vasculitis: a case report.
Int J Crit Illn Inj Sci, 11 (2021), pp. 39-42
Copyright © 2022. Sociedad Española de Médicos de Atención Primaria (SEMERGEN)
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.semerg.2023.102132
No mostrar más